Global Pharmaceuticals for Women's Health Market 2019-2025: Focus on Menopause-related Disorders, Postmenopausal Osteoporosis, Endometriosis, Polycystic Ovarian Syndrome and Pregnancy Disorder - ResearchAndMarkets.com

The "Pharmaceuticals for Women's Health: Global Markets" report has been added to ResearchAndMarkets.com's offering.

While women's health encompasses several health issues, this report will focus on menopause-related disorders, postmenopausal osteoporosis, endometriosis, polycystic ovarian syndrome and pregnancy disorders.

The report includes:

• Detailed overview of the global markets for pharmaceuticals for women's health and identification of the main women's health disorders
• Analyses of market trends, with data from 2019, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Evaluation of the impact of demographic, economic and other factors that will drive future demand in the women's health therapeutics market
• A look at the unmet needs in women's health therapeutics and details of the promising new drugs and therapies that are still in development and testing stage
• Market forecast of the potential drugs in the pipeline, information on late-stage pipeline drugs and overview of osteoporosis drug development
• Insights into government concerns and initiatives towards women's health
• Highlights of current and future market potential and a detailed analysis of the current market size, and regulatory scenarios
• Market share analysis of leading drug manufacturers and detailed coverage of women's health therapeutics industry in terms of different events like mergers and acquisitions, agreements, collaborations, and partnerships
• Company profiles of the leading suppliers of the industry including AbbVie Inc., Bayer AG, Daiichi Sankyo Co. Ltd., Eli Lilly and Co., Johnson & Johnson Inc. and Merck KGaA

Key Topics Covered

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• Information Sources
• Methodology
• Geographic Breakdown

Chapter 2 Summary and Highlights

Chapter 3 Technologies and Global Markets Overview

• Disease Overview and Definitions
• Market Driving Factors and Opportunities
  • Aging Female Population
  • Government Involvement and Increased Funding
  • Increasing Awareness Regarding Women's Disorders and Treatments
• Market Restraints
  • Poor Diagnosis
  • Availability of Alternate Treatment Options and Lifestyle Changes
  • Unavailability of Novel Treatments
  • High Cost of Treatment

Chapter 4 Pipeline Assessment and Analysis

• Drugs in the Pipeline
• Overview of Osteoporosis Drug Development Pipeline
• Late-Stage Pipeline Drugs
  • Relugolix (Myovant Sciences)
  • Proellex (Repros Therapeutics)

Chapter 5 Regulatory Structure

• Overview of Regulations
  • United States
  • Canada
  • Europe
  • Japan
• Overview of Pricing and Reimbursement
  • United States
  • Canada
  • Europe
  • Japan

Chapter 6 Market Breakdown by Women's Health Condition, Disorder and Disease

• Introduction
• Menopause
  • Overview
  • Symptoms
  • Risk Factors
  • Epidemiology and Economic Burden
  • Diagnosis
  • Treatments
  • Market Size and Forecasts
• Postmenopausal Osteoporosis
  • Overview
  • Epidemiology and Economic Burden
  • Diagnosis
  • Treatments
  • Market Size and Forecasts
• Endometriosis
  • Overview
  • Epidemiology and Economic Burden
  • Diagnosis
  • Treatments
  • Market Size and Forecasts
• Polycystic Ovary Syndrome (PCOS)
  • Overview
  • Reducing the Risk of PCOS
  • Epidemiology and Economic Burden
  • Diagnosis
  • Treatments
  • Market Size and Forecasts
• Pregnancy Disorders and Management
  • Overview
  • Market Size and Forecasts
• Others
  • Overview
  • Market Size and Forecasts

Chapter 7 Market Breakdown by Region

• Introduction
• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific
• South America
• Middle East and Africa

Chapter 8 Competitive Landscape and Key Developments

• Market Players and Strategies
• Patent Analysis
• Key Patents
• Key Developments
• Mergers and Acquisitions
• Development of Innovative Products/Novel Product Launch
• Agreements, Collaborations and Partnerships
• Key Products

Chapter 9 Company Profiles

• Abbvie Inc.
• Allergan PLC
• Amgen Inc.
• Bayer AG
• Daiichi Sankyo Co. Ltd.
• Eli Lilly and Co.
• Johnson & Johnson Inc.
• Merck KGaA
• Novo Nordisk
• Pfizer Inc.

For more information about this report visit https://www.researchandmarkets.com/r/7kx2f

View source version on businesswire.com: https://www.businesswire.com/news/home/20200825005472/en/